Inhalon Biopharma
Company Details
Status: Private
Employees: 1-10
Location:
Carrboro, North Carolina, United States
Type:
sample
Technology:
sample
sample
About: Inhalon Biopharma is developing an inhaled immunotherapy platform for treating acute respiratory infections (ARI), such as syncytial virus (RSV), influenza, metapneumovirus (MPV), parainfluenza virus (PIV), adenovirus, severe acute respiratory syndrome (SARS) and middle east respiratory syndrome (MERS). Today there are no approved treatments for a wide range of ARIs that can lead to hospitalization, long-term health complications and sometimes death.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!

Inhalon Biopharma | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.